KFAS
KRRO icon

Keating Financial Advisory Services’s Korro Bio KRRO Stock Holding History

Keating Financial Advisory Services’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-63
Closed -$713 – 2667
2026
Q1 		$713 Hold
63
– – ﹤0.01% 2180
2025
Q4 		$505 Buy
+63
New +$1.47K ﹤0.01% 1945

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Keating Financial Advisory Services's KRRO Position: Q2 2026 in Review

Keating Financial Advisory Services sold out of Korro Bio (KRRO) in Q2 2026, closing a stake of 63 shares — an estimated $713 sold.

Keating Financial Advisory Services first reported a position in KRRO in Q4 2025 and held it in 2 quarters. The position peaked at $713 in Q1 2026. 107 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Keating Financial Advisory Services reported no remaining Korro Bio position as of Q2 2026 after selling out during the quarter.
  • Keating Financial Advisory Services sold 63 Korro Bio shares in Q2 2026, an estimated $713.
  • Keating Financial Advisory Services first reported a position in Korro Bio in Q4 2025 and held it in 2 quarters.
  • Keating Financial Advisory Services's Korro Bio position peaked at $713 in Q1 2026.
  • 107 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.